Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Information
NCT06790940 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 310
Last updated 2025-01-24
Summary
Psoriasis is a globally prevalent chronic relapsing skin disease, characterized by its long duration and tendency to relapse. In addition to skin symptoms, it can also affect nails and joints, leading to pathological features such as pitting, leukonychia, red lunula, or severe nail dystrophy. Some patients with psoriasis may develop psoriatic arthritis. Psoriatic arthritis (PsA) is a chronic relapsing musculoskeletal disease, characterized by psoriatic skin lesions accompanied by axial and peripheral joint damage, and often associated with characteristic manifestations of psoriatic nails. These nail changes typically indicate more severe disease and poorer prognosis. However, current diagnostic methods largely depend on the experience and professional knowledge of clinicians, which are subjective and uncertain. Moreover, histopathological examination is invasive and can cause additional pain and inconvenience to patients.
To develop an effective, convenient, and non-invasive early diagnostic tool for psoriasis, our research team has conducted in-depth studies in the field of psoriasis-related diagnosis and predictive models. We have successfully developed a predictive model for psoriatic arthritis, including six key predictive factors: history of joint swelling, history of arthritis, history of swelling and pain in fingers or toes, nail involvement, genital involvement, and a history of long-term local use of corticosteroids. Clinicians can effectively assess the risk of psoriatic arthritis by obtaining information about these six factors from patients. The paper "Early detection of psoriatic arthritis in patients with psoriasis: construction of a multifactorial prediction model" was published in Front. Immunol (DOI: 10.3389/fimmu.2024.1426127).
Raman spectroscopy is a rapid, non-invasive molecular vibration detection method that has shown great potential in medical diagnostics. Studies have shown that Raman spectroscopy can distinguish normal and abnormal tissues at the molecular level and has been proven feasible in nail testing. For psoriasis, a disease that causes significant nail changes, Raman spectroscopy offers unique advantages.
Based on this background, our project will conduct a prospective observational study on psoriasis and psoriatic arthritis using multidimensional nail data. We will integrate Raman spectroscopy data of nails and multidimensional clinical information and apply artificial intelligence algorithms to develop a new diagnostic tool for psoriasis and psoriatic arthritis. This tool aims to improve the accuracy and efficiency of diagnosis, providing strong support for the early detection and precise treatment of psoriasis and psoriatic arthritis.
Conditions
- Psoriasis (PsO)
- Psoriatic Arthritis
- Palmoplantar Pustulosis (PPP)
- Plaque Psoriasis
Interventions
- OTHER
-
No intervention
This is an observational study, no intervention will be implemented.
Sponsors & Collaborators
-
Shanghai 10th People's Hospital
collaborator OTHER -
Shanghai Yueyang Integrated Medicine Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-01-20
- Primary Completion
- 2026-12-01
- Completion
- 2026-12-01
More Related Trials
-
Study of Psoriatic Arthritis
NCT00001420 ·Status: COMPLETED
-
The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab)
NCT02693470 ·Status: UNKNOWN ·Phase: PHASE4
-
The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis
NCT01504113 ·Status: UNKNOWN
-
IL-17 Role in Variants of Psoriasis
NCT02078297 ·Status: COMPLETED
-
A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers
NCT07149792 ·Status: RECRUITING ·Phase: PHASE4
-
Sonographic Analysis of Nails in Psoriatic Arthritis and Healthy Controls
NCT04718428 ·Status: COMPLETED
-
COVID-19 Associated With Psoriasis
NCT05961605 ·Status: UNKNOWN
-
Cytokine Expression in Psoriasis Patients with and Without Joint Involvement
NCT05307809 ·Status: RECRUITING ·Phase: NA
-
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
NCT00893126 ·Status: COMPLETED
-
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
NCT02330380 ·Status: COMPLETED
-
Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
NCT06802848 ·Status: NOT_YET_RECRUITING
-
A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
NCT02016482 ·Status: COMPLETED ·Phase: PHASE3
-
Immunoclassification of Psoriasis: a Strategy for Precision Medicine
NCT05503875 ·Status: RECRUITING ·Phase: NA
-
Regulation of Inflammatory Genes in Psoriasis
NCT03125655 ·Status: RECRUITING
-
Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot Study
NCT05925842 ·Status: UNKNOWN
-
The Study of Koebner in Patients With Psoriasis and Psoriatic Arthritis
NCT05589298 ·Status: COMPLETED
-
Ultrasound Study of Entheses and Small Joints of Hands and Feet in Patients With Atypical Form of Psoriasis
NCT02899429 ·Status: COMPLETED
-
Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity
NCT02602925 ·Status: COMPLETED ·Phase: PHASE4
-
AsseSSing Impact in pSoriatic Treatment
NCT05171270 ·Status: COMPLETED
-
Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis
NCT06811558 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis
NCT01657513 ·Status: UNKNOWN ·Phase: NA
-
Chinese Psoriasis Real World Evidence Research
NCT04465838 ·Status: RECRUITING
-
A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China
NCT03236870 ·Status: COMPLETED
-
Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab
NCT03099083 ·Status: COMPLETED
-
Psoriatic Inflammation Markers Predictive of Response to Adalimumab
NCT03389984 ·Status: COMPLETED ·Phase: NA